Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,852,727
-
Share change
-
-765,959
-
Total reported value
-
$7,069,000
-
Price per share
-
$1.21
-
Number of holders
-
47
-
Value change
-
-$1,596,854
-
Number of buys
-
21
-
Number of sells
-
22
Institutional Holders of ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) as of Q4 2015
As of 31 Dec 2015,
ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,852,727 shares.
The largest 10 holders included
BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Allianz Asset Management AG, Connor, Clark & Lunn Investment Management Ltd., Abingworth LLP, BRIDGEWAY CAPITAL MANAGEMENT INC, BlackRock Advisors LLC, EAGLE GLOBAL ADVISORS LLC, and Alambic Investment Management, L.P..
This page lists
47
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.